A recent article in Nature highlighted an upcoming collaborative gender analysis by the AMR Policy Accelerator and the World Health Organization. This research examines how women, men, and gender-diverse populations can experience heightened risk to drug-resistant infections. Considerations of how gender can impact health behaviours is crucial to mitigating AMR. Key policy recommendations have been put forth to promote more equitable health outcomes.
The technical brief, featuring key recommendations for policymakers based on the analysis, will be released on July 11th during a WHO webinar focused on gender inequalities in national action plans for antimicrobial resistance.
To learn more, you can read the full article on Nature here.
Previous